Point72 Asset Management’s Arbutus Biopharma ABUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-105,000
Closed -$263K 2119
2023
Q4
$263K Buy
+105,000
New +$206K ﹤0.01% 1734
2021
Q4
Sell
-895,200
Closed -$3.84M 1063
2021
Q3
$3.84M Sell
895,200
-104,800
-10% -$349K 0.02% 708
2021
Q2
$3.03M Sell
1,000,000
-37,700
-4% -$117K 0.02% 685
2021
Q1
$3.46M Buy
+1,037,700
New +$4M 0.02% 646
2020
Q1
Sell
-1,897,284
Closed -$5.27M 749
2019
Q4
$5.27M Buy
+1,897,284
New +$3.07M 0.03% 491
2017
Q4
Sell
-224,655
Closed -$1.39M 881
2017
Q3
$1.39M Buy
+224,655
New +$961K 0.01% 710
2015
Q3
Sell
-360,800
Closed -$4.28M 746
2015
Q2
$4.28M Buy
360,800
+203,600
+130% +$3.1M 0.03% 470
2015
Q1
$2.75M Buy
+157,200
New +$3.22M 0.02% 525

Other funds holding ABUS